Cancer Treatment News and Research

RSS

Diet, lifestyle and environment attribute to the cause of majority of cancer cases

Diet, lifestyle and the environment are all factors attributed to the cause of the majority of cancer cases and it has been estimated that up to half of all cancers may be preventable according to research by a University of Leicester scientist.

19 Jun 2013

Paper published by GWCI addresses the value of patient navigation programs for community cancer centers

A recently published paper by the George Washington University Cancer Institute (GWCI) addresses the value of patient navigation programs for community cancer centers.

19 Jun 2013

Scientists discover molecular pathway that can prevent death of oocytes due to chemotherapy

Young women who have cancer treatment often lose their fertility because chemotherapy and radiation can damage or kill their immature ovarian eggs, called oocytes. Now, Northwestern Medicine- scientists have found the molecular pathway that can prevent the death of immature ovarian eggs due to chemotherapy, potentially preserving fertility and endocrine function.

18 Jun 2013

Bioapplications of nanoparticles: an interview with Dr Catherine Berry, University of Glasgow

These particles are all classed as inorganic particles, which can all be utilised in biomedical applications. They differ in terms of their inherent material and size dependent physiochemical properties, for example, their optical and magnetic properties.

18 Jun 2013

New CREHST program aims to expose students to clinical aspect of cancer research

Building off the success of its Continuing Umbrella for Research Education Program that encourages underrepresented minority undergraduate and high school students to pursue careers in healthcare, the Cancer Institute of New Jersey is offering a related program focusing on clinical research.

18 Jun 2013

Adults formerly treated for childhood cancer have chronic health problems

In an analysis that included more than 1,700 adult survivors of childhood cancer, researchers found a very high percentage of survivors with 1 or more chronic health conditions, with an estimated cumulative prevalence of any chronic health condition of 95 percent at age 45 years, according to a study in the June 12 issue of JAMA.

14 Jun 2013

Viewpoints: Administration 'finally' comes around on Plan B; 'Legal loophole' creates another compounded drug scare

Reluctantly yielding to a federal-court decision, the Obama administration announced on Monday that it will take steps to allow a version of the so-called morning-after pill, known as Plan B One-Step, to be sold over the counter to girls and women of all ages. They will not need a prescription, nor will they be required to show any identification to obtain the emergency contraceptive. There will be no restrictions on where the drug can be sold; it will be up to the manufacturer to propose appropriate venues (6/11).

13 Jun 2013

Radionuclide drug treatment planning goes to next level with 3-D patient models

External beam radiation treatment has long been manipulated into the unique shape of patients' tumors for personalized cancer care. Technology providing a means of patient-specific radionuclide drug therapies has not been standardized, as it has been limited to software that requires oncologists to manually define the areas of tumors.

13 Jun 2013

Study provides complete health picture of adult survivors of childhood cancer

St. Jude Children's Research Hospital has found that childhood cancer survivors overwhelmingly experience a significant amount of undiagnosed, serious disease through their adult years, establishing the importance of proactive, life-long clinical health screenings for this growing high-risk population.

12 Jun 2013

Integrating exercise into cancer follow-up care can improve recovery, say Miriam Hospital researchers

Telephone-based counseling, when combined with physician advice, can help breast cancer survivors become more physically active, which can improve quality of life and lessen the side effects of cancer treatment, according to new research from The Miriam Hospital.

12 Jun 2013

PSMA enzyme could become hallmark of new generation of biomarkers for prostate cancer treatment

No matter where they have hidden, metastatic prostate cancer cells still express some of the same signaling as normal prostate cells; in some cases even more so, as with the PSMA enzyme. Harnessing this enzyme could mean the beginning of a new platform for prostate cancer detection, staging, treatment and post-treatment monitoring, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.

12 Jun 2013

Countrywide study in Germany deems PRRT as life-prolonging treatment for patients with NETs

Peptide-receptor radionuclide therapy has been a subject of growing research on neuroendocrine tumors, which take up residence in a variety of organs replete with nerve cells that respond to hormone signaling.

12 Jun 2013

Prostate cancer and DNA: an interview with Dr. Jianfeng Xu, Wake Forest School of Medicine

Prostate cancer development is associated with both inherited and acquired genetic alterations. More than 70 inherited genetic variants have been consistently identified in human DNA that may contribute to susceptibility or risk of prostate cancer.

11 Jun 2013

Combination of cell-killing radioactive particle and antibody is safe for treating cancers

An experimental treatment that combines a cell-killing radioactive particle with an antibody that homes in on cancer cells is safe in the treatment of cancers spreading through patients' abdomens, according to data from a first-in-human study presented today at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver.

11 Jun 2013

State roundup: Calif. inches to budget deal; Iowa's Medicaid abortions may need gov. OK

The U.S. Supreme Court says women in America can terminate a pregnancy and that every citizen has an individual right to own a firearm, but those rulings have done little to settle political arguments over abortion and guns. The result is an uneven medley of state laws, which means that just how you can exercise those constitutional rights depends on where you live, and the differences often turn on whether a state is run by Democrats or Republicans (Barrow, 6/8).

11 Jun 2013

SUNY Downstate to receive grant to advance blood test to predict breast cancer progression

SUNY Downstate Medical Center will receive up to $50,000 from the statewide SUNY Technology Accelerator Fund to advance a blood test to determine breast cancer prognosis.

10 Jun 2013

Inflection Biosciences signs license agreement with CNIO to develop kinase inhibitors for cancer treatment

Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule treatments for cancer, today announced that it has entered into a license agreement with the Spanish National Cancer Research Centre (CNIO) for the exclusive, worldwide rights to develop and commercialise several novel kinase inhibitors for the treatment of cancer.

6 Jun 2013

CTCA offers hope to Hispanics with advanced stage cancer

For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.

6 Jun 2013

Accuray announces treatment of first patient with new TomoHDA System

Accuray Incorporated, announced today the first patient has been treated with its new TomoHDA System at Centre Oscar Lambret in Lille, France.

5 Jun 2013

Report: 83% of cancer doctors face oncology drug shortages

Eighty-three percent of cancer doctors report that they've faced oncology drug shortages, and of those, nearly all say that their patients' treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 2013 annual meeting of the American Society of Clinical Oncology (Abstract #CRA6510).

4 Jun 2013

Cancer Treatment News and Research

Diet, lifestyle and environment attribute to the cause of majority of cancer cases

Paper published by GWCI addresses the value of patient navigation programs for community cancer centers

Scientists discover molecular pathway that can prevent death of oocytes due to chemotherapy

Bioapplications of nanoparticles: an interview with Dr Catherine Berry, University of Glasgow

New CREHST program aims to expose students to clinical aspect of cancer research

Adults formerly treated for childhood cancer have chronic health problems

Viewpoints: Administration 'finally' comes around on Plan B; 'Legal loophole' creates another compounded drug scare

Radionuclide drug treatment planning goes to next level with 3-D patient models

Study provides complete health picture of adult survivors of childhood cancer

Integrating exercise into cancer follow-up care can improve recovery, say Miriam Hospital researchers

PSMA enzyme could become hallmark of new generation of biomarkers for prostate cancer treatment

Countrywide study in Germany deems PRRT as life-prolonging treatment for patients with NETs

Prostate cancer and DNA: an interview with Dr. Jianfeng Xu, Wake Forest School of Medicine

Combination of cell-killing radioactive particle and antibody is safe for treating cancers

State roundup: Calif. inches to budget deal; Iowa's Medicaid abortions may need gov. OK

SUNY Downstate to receive grant to advance blood test to predict breast cancer progression

Inflection Biosciences signs license agreement with CNIO to develop kinase inhibitors for cancer treatment

CTCA offers hope to Hispanics with advanced stage cancer

Accuray announces treatment of first patient with new TomoHDA System

Report: 83% of cancer doctors face oncology drug shortages

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News